TITLE:
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

CONDITION:
Bone Neoplasms

INTERVENTION:
MK0663, etoricoxib / Duration of Treatment: 4 weeks

SUMMARY:

      The purpose of this study is to compare the effectiveness of an investigational drug versus
      placebo in the treatment of metastatic bone cancer pain in patients diagnosed with breast or
      prostate cancer and a bone neoplasm. Patients in the study will be taking opioids to treat
      moderate to severe pain for their bone metastases and will remain on their opioids during
      the entire course of the study.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patients are required to have a diagnosis of breast or prostate cancer with bone
             involvement and moderate to severe pain that requires opioid treatment.
      
